Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
IABP for Cardiogenic Shock – Cardiology MCQ
4 Comments | Jan 19, 2019
-
High risk syncope – Cardiology MCQ – Answer
No Comments | Apr 30, 2018 -
Disadvantages of perioperative heparin bridging – Cardiology MCQ
No Comments | Dec 25, 2016 -
Truncus arteriosus – Cardiology MCQ
No Comments | May 10, 2016
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal